Express News | Corrected-Buzz-U.S. Stocks on the Move-AMC, Alnylam, Super Micro

Reuters11:34 ET

Sector Update: Health Care Stocks Edge Higher Premarket Monday

MT NewswiresNov 25 09:09 ET

BMO Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $300

Moomoo NewsNov 25 07:39 ET · Ratings

Express News | Alnylam Pharmaceuticals Inc - Vutrisiran Shows Encouraging Safety and Tolerability

ReutersNov 25 07:00 ET

Express News | Alnylam Pharmaceuticals Inc - FDA Sets Pdufa Date for Vutrisiran on March 23, 2025

ReutersNov 25 07:00 ET

Express News | Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of Attr Amyloidosis With Cardiomyopathy

ReutersNov 25 07:00 ET